Home Tags Ranibizumab

Tag: Ranibizumab

Lupin Completes Phase 3 Trials for Lucentis Biosimilar

0
Lupin Limited announced the successful completion of global Phase 3 trials for its Lucentis (ranibizumab) biosimilar, LUBT010. This trial, involving 600 patients from India,...
15,925FansLike
1,951FollowersFollow
155SubscribersSubscribe
Global Market Updates

EDITOR PICKS